Last updated on February 2019

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Brief description of study

This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).

Clinical Study Identifier: NCT03523858

Contact Investigators or Research Sites near you

Start Over

The Elliot Lewis Center

Wellesley, MA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.